Arbutus Biopharma Insider Trades

ABUS

Track insider trading activity from Arbutus Biopharma executives and directors. See which insiders are buying and selling ABUS stock.

Trades Last 12 Months

ABUS Price

All Insider Trades for Arbutus Biopharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $351k 78,800 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$334k 78,800 shares
$4.24
$4.46
Sawhney Roger Director
Holding Value $351k 78,800 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$334k 78,800 shares
$4.24
$4.46
Nguyen Tuan Chief Financial Officer
Holding Value $840k 188,400 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 261,900 shares
$4.39
$4.46
Androski Lindsay President And CEO
Holding Value $320k 71,700 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$438k 99,700 shares
$4.39
$4.46
Hasija Anuj Director
Holding Value $703k 157,600 shares
Last Trade
Mar 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$504k 157,600 shares
$3.20
$4.46
Mcelhaugh Michael J. Interim President & CEO
Holding Value $7.39M 1,658,003 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36M 718,800 shares
$3.29
$4.46
Hastings David C Chief Financial Officer
Holding Value $1.63M 365,800 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 365,800 shares
$3.29
$4.46
Sims Karen Chief Medical Officer
Holding Value $893k 200,300 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$659k 200,300 shares
$3.29
$4.46
Naftzger J. Christopher General Counsel And CCO
Holding Value $983k 220,300 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$725k 220,300 shares
$3.29
$4.46
Holding Value $245k 54,915 shares
Last Trade
Aug 14, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 54,915 shares
$3.68
$4.46
Torti Frank Director
Holding Value $299k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.46
Holding Value $299k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.46
Meyers James R Director
Holding Value $299k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.46
Burgess Daniel D Director
Holding Value $299k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.46
Holding Value $299k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.46
Sofia Michael J. Chief Scientific Officer
Holding Value $6.62M 1,485,121 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.1k 9,982 shares
$2.31
$4.46
Howard Elizabeth Evp, Gc, Compliance
Holding Value $1.24M 278,700 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 348,400 shares
$2.90
$4.46
Collier William H. President And CEO
Holding Value $3.86M 866,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.14M 1,082,500 shares
$2.90
$4.46
Mc Elhaugh Michael J. Chief Business Officer
Holding Value $6.2M 1,391,157 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 83,700 shares
$2.90
$4.46
Tran Tram Director
Holding Value $183k 41,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$92.3k 41,000 shares
$2.25
$4.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up